XML 36 R26.htm IDEA: XBRL DOCUMENT v3.6.0.2
Equity Instruments (Tables)
6 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The assumptions used for the six months ended December 31, 2016 are as follows:
 
Expected volatility
 
 
182% - 185%
 
Risk free interest rate
 
 
0.97 % - 1.14%
 
Expected term (years)
 
 
5.0 - 6.5
 
Dividend yield
 
 
0%
 
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Stock option activity is as follows:
 
 
 
 
 
Weighted
 
Weighted Average
 
 
 
Number of
 
Average
 
Remaining Contractual
 
 
 
Options
 
Exercise Price
 
Life in Years
 
Outstanding June 30, 2016
 
 
322,302
 
$
18.01
 
 
9.33
 
Granted
 
 
441,999
 
$
3.23
 
 
 
 
Exercised
 
 
-
 
$
-
 
 
 
 
Forfeited/Cancelled
 
 
(17,646)
 
$
4.99
 
 
 
 
Outstanding December 31, 2016
 
 
746,655
 
$
3.52
 
 
9.21
 
Exercisable at December 31, 2016
 
 
323,755
 
$
3.40
 
 
9.10
 
Available for grant at December 31, 2016
 
 
1,253,345
 
 
 
 
 
 
 
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
The following table summarizes stock-based compensation expense for the three and six months ended December 31, 2016 and three and six months ended December 31, 2015:
 
 
 
Three Months Ended December 31,
 
Six Months Ended December 31,
 
 
 
2016
 
2015
 
2016
 
2015
 
Research and development expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock options
 
$
-
 
$
20,000
 
$
-
 
$
25,000
 
Selling, general and administrative expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock options
 
 
381,000
 
$
163,000
 
 
1,425,000
 
 
226,000
 
 
 
$
381,000
 
$
183,000
 
$
1,425,000
 
$
251,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unrecognized expense at December 31, 2016
 
$
1,435,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average remaining years to vest
 
 
2.26
 
 
 
 
 
 
 
 
 
 
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
A summary of all warrants is as follows:
 
 
 
 
 
 
 
Weighted Average Remaining
 
 
 
Number of Warrants
 
Weighted Average Exercise Price
 
Contractual Life in Years
 
Outstanding June 30, 2016
 
 
2,201,627
 
$
6.19
 
 
4.71
 
 
 
 
 
 
 
 
 
 
 
 
Issuance of settlement warrants to initial investors
 
 
88,032
 
$
4.00
 
 
 
 
Warrants issued to investors in connection with the registered offering
 
 
6,020,245
 
$
1.86
 
 
 
 
Warrants issued to placement agents for the registered offering
 
 
401,450
 
$
1.86
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding December 31, 2016
 
 
8,711,354
 
$
2.98
 
 
4.51
 
Schedule of Share-based Payment Award, Warrants, Valuation Assumptions [Table Text Block]
Significant assumptions in valuing the warrants issued during the December 31, 2016 quarter were as follows:
 
Expected volatility
 
 
186.7% - 229.8%
 
Risk free interest rate
 
 
1.02% - 1.33%
 
Contractual term (years)
 
 
4.68 - 5.0
 
Dividend yield
 
 
0%